Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Letters

• Publication date

  2017-03-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.canlet.2016.11.030PMID 27916607PMCID PMC5318282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

  2018cited by this paper
• Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.

  2017cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Final analysis of stage 1 data from a randomized phase II study of PEGPH20 plus nab-Paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients (pts), utilizing Ventana companion diagnostic assay.

  2016cited by this paper
• Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.

  2016cited by this paper
• EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.

  2016cited by this paper
• Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer

  2016cited by this paper
• Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models

  2016cited by this paper
• Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells

  2016cited by this paper
• ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer

  2016cited by this paper
• IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer

  2016cited by this paper
• Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

  2016cited by this paper
• Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy.

  2016cited by this paper
• Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

  2016cited by this paper
• Urokinase receptor and resistance to targeted anticancer agents

  2015cited by this paper
• Activatable Ferritin Nanocomplex for Real-Time Monitoring of Caspase-3 Activation during Photodynamic Therapy.

  2015cited by this paper
• Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.

  2015cited by this paper
• A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer.

  2015cited by this paper
• Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

  2015cited by this paper
• IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.

  2015cited by this paper
• Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

  2015cited by this paper
• Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.

  2015cited by this paper
• Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles.

  2014cited by this paper
• ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens.

  2014cited by this paper
• Enhancement of phototoxicity against human pancreatic cancer cells with photosensitizer-encapsulated amphiphilic sodium alginate derivative nanoparticles.

  2014cited by this paper
• Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.

  2014cited by this paper
• Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer

  2014cited by this paper
• Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.

  2014cited by this paper
• Pancreatic cancer gene therapy using an siRNA-functionalized single walled carbon nanotubes (SWNTs) nanoplex.

  2014cited by this paper
• Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer

  2014cited by this paper
• Mucins in pancreatic cancer and its microenvironment

  2013cited by this paper
• Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

  2013cited by this paper
• Delivery materials for siRNA therapeutics.

  2013cited by this paper
• Impact of Adjuvant Radiotherapy on Survival after Pancreatic Cancer Resection: An Appraisal of Data from the National Cancer Data Base

  2013cited by this paper
• Pancreatic cancer.

  2013cited by this paper
• uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection

  2013cited by this paper
• Targeting the insulin-like growth factor-1 receptor in human cancer

  2013cited by this paper
• Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model

  2013cited by this paper
• Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

  2013cited by this paper
• Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation

  2013cited by this paper
• Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer

  2013cited by this paper
• Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer

  2013cited by this paper
• Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment

  2013cited by this paper
• Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

  2013cited by this paper
• Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.

  2013cited by this paper
• Corrigendum to “Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy” [Nanomed Nanotechnol Biol Med. 2011;7:859–870]

  2013cited by this paper
• Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.

  2012cited by this paper
• Mesothelin-Targeted Agents in Clinical Trials and in Preclinical Development

  2012cited by this paper
• Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway

  2012cited by this paper
• Pancreatic cancer: between bench and bedside.

  2012cited by this paper
• A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer

  2012cited by this paper
• Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma

  2012cited by this paper
• Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.

  2012cited by this paper
• Early diagnosis of pancreatic cancer: challenges and new developments.

  2012cited by this paper
• RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy

  2012cited by this paper
• A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

  2012cited by this paper
• Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

  2011cited by this paper
• Randomized phase II study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer.

  2011cited by this paper
• Overcoming drug resistance in pancreatic cancer

  2011cited by this paper
• Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.

  2011cited by this paper
• Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

  2011cited by this paper
• Serum Biomarker Panels for the Detection of Pancreatic Cancer

  2011cited by this paper
• EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.

  2011cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• Plectin-1 as a Novel Biomarker for Pancreatic Cancer

  2010cited by this paper
• Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.

  2010cited by this paper
• Preclinical molecular imaging of tumor angiogenesis.

  2010cited by this paper
• Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.

  2010cited by this paper
• Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.

  2009cited by this paper
• Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.

  2009cited by this paper
• Transcriptional Regulation of Urokinase-type Plasminogen Activator Receptor by Hypoxia-inducible Factor 1 Is Crucial for Invasion of Pancreatic and Liver Cancer 1

  2009cited by this paper
• Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.

  2009cited by this paper
• Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy.

  2009cited by this paper
• Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts

  2009cited by this paper
• Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer

  2009cited by this paper
• Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.

  2008cited by this paper
• Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

  2008cited by this paper
• HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy

  2008cited by this paper
• Nuclear translocation of urokinase-type plasminogen activator.

  2008cited by this paper
• Plakins in development and disease.

  2007cited by this paper
• Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• In vivo Therapeutic Synergism of Anti–Epidermal Growth Factor Receptor and Anti-HER2 Monoclonal Antibodies against Pancreatic Carcinomas

  2007cited by this paper
• Control of human mesothelin-expressing tumors by DNA vaccines

  2007cited by this paper
• Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma

  2007cited by this paper
• In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy

  2006cited by this paper
• RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.

  2005cited by this paper
• Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.

  2005cited by this paper
• In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe

  2004cited by this paper
• Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.

  2004cited by this paper
• The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors.

  2003cited by this paper
• The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy

  2003cited by this paper
• Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.

  2003cited by this paper
• Magnetic resonance molecular imaging of the HER-2/neu receptor.

  2003cited by this paper
• Photodynamic therapy for cancer of the pancreas

  2002cited by this paper
• Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

  2001cited by this paper
• Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma

  2001cited by this paper
• [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].

  2000cited by this paper
• Strahlentherapeutische Strategien in der multimodalen Therapie des resektablen und nicht resektablen Pankreaskarzinoms

  2000cited by this paper
• Not just scaffolding: plectin regulates actin dynamics in cultured cells.

  1998cited by this paper

• Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology

  2026cites this paper
• Harnessing nano-delivery systems to un-cover the challenges for cervical cancer therapy.

  2025cites this paper
• Innovative nanoparticle-based therapies for pancreatic neuroendocrine tumours (PNETs): advances, challenges, and future directions

  2025cites this paper
• Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy

  2025cites this paper
• Advances in cancer therapy: a critical review of β-cyclodextrins conjugated nanoparticle delivery systems as molecularly targeted therapies.

  2025cites this paper
• Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies

  2025cites this paper
• In vitro evaluation of the therapeutic efficacy of Moringa oleifera and oxaliplatin in 3D printed polycaprolactone/gelatin implantable patches: A potential strategy for overcoming drug resistance in colorectal cancer treatment.

  2025cites this paper
• Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer.

  2024cites this paper
• Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis

  2024cites this paper
• Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics

  2024cites this paper
• Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer

  2024cites this paper
• Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging

  2024cites this paper
• CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers

  2024cites this paper
• Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455–3p/HDAC4

  2023cites this paper
• Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression

  2023cites this paper
• Autophagy is involved in Ficus carica fruit extract-induced anti-tumor effects on pancreatic cancer.

  2022cites this paper
• State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer

  2022cites this paper
• Exploring the translational challenge for medical applications of ionising radiation and corresponding radiation protection research

  2022cites this paper
• Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

  2021cites this paper
• Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer

  2021cites this paper
• Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy

  2021cites this paper
• c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models.

  2021cites this paper
• Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

  2021cites this paper
• Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance

  2021cites this paper
• Design and Encapsulation of Immunomodulators onto Gold Nanoparticles in Cancer Immunotherapy

  2021cites this paper
• Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?

  2021cites this paper
• Microbubble-Mediated Cavitation Promotes Apoptosis and Suppresses Invasion in AsPC-1 Cells.

  2020cites this paper
• Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation with Near-Infrared Fluorescence Heptamethine Carbocyanine Dye.

  2020cites this paper
• Ultrasound-Activated Cascade Effect for Synergistic Orthotopic Pancreatic Cancer Therapy

  2020cites this paper
• Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?

  2020influential citation
• Polyunsaturated Fatty Acid-Loaded Nanomedicine for Solid Tumor

  2020cites this paper
• Nanotechnology for angiogenesis: opportunities and challenges.

  2020cites this paper
• Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers

  2020cites this paper
• Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer.

  2020cites this paper
• An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment

  2020cites this paper
• Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.

  2020cites this paper
• Application of Nanotechnology in Early Detection of Gastrointestinal Cancer

  2020cites this paper
• New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors

  2020cites this paper
• PANCREATIC CANCER, CURRENT THERAPEUTIC APPROACHES AND POSSIBLE PROSPECTS

  2020influential citation
• Latest developments in chemotherapy for metastatic pancreatic cancer

  2019cites this paper
• Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging.

  2019cites this paper
• CMAR_A_208054 5961..5969

  2019cites this paper
• Dual and multi-targeted nanoparticles for site-specific brain drug delivery.

  2019cites this paper
• Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery

  2019cites this paper
• Synthesis and Processing of Nanocapsules of Single and Multiple Cancer Drugs for Targeted Cancer Therapy

  2019cites this paper
• SNHG15: a promising cancer-related long noncoding RNA

  2019cites this paper
• IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling

  2019cites this paper
• Theranostic Nanoparticles for Tracking and Monitoring Disease State

  2018cites this paper
• Synthesis and characterization of silica‐coated superparamagnetic iron oxide nanoparticles and interaction with pancreatic cancer cells

  2018cites this paper
• Carbon Dots‐Cluster‐DOX Nanocomposites Fabricated by a Co‐Self‐Assembly Strategy for Tumor‐Targeted Bioimaging and Therapy

  2018cites this paper
• Single X-ray crystal structure, DFT studies and topoisomerase I inhibition activity of a tailored ionic Ag(I) nalidixic acid–piperazinium drug entity specific for pancreatic cancer cells

  2018cites this paper
• Nanoscale delivery systems for cancer immunotherapy

  2018cites this paper
• Preclinical Toxicology Evaluation

  2018cites this paper
• Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially-expressed circRNAs, lncRNAs, miRNAs and mRNAs

  2018cites this paper
• A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.

  2018cites this paper
• Theranostic Hyaluronic Acid–Iron Micellar Nanoparticles for Magnetic‐Field‐Enhanced in vivo Cancer Chemotherapy

  2018cites this paper
• Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft

  2017cites this paper
• Dermokine contributes to epithelial–mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer

  2017cites this paper
• Overcoming key biological barriers to cancer drug delivery and efficacy.

  2017cites this paper
• Fabrication of multifunctional ferric oxide nanoparticles for tumor-targeted magnetic resonance imaging and precise photothermal therapy with magnetic field enhancement.

  2017cites this paper
• Nanoparticles for death‑induced gene therapy in cancer (Review).

  2017cites this paper
• NEW ADVANCES IN STRATEGIES OF NANOTECHNOLOGY TO OVERCOME PANCREATIC CANCER

  year unknowncites this paper